ABBVIE, INC. for ABBVIE INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2017 | $1,200,000 | Replaced |
| 3rd Quarter - Amendment | Mar 28, 2019 | $1,230,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 124: Preserve Access to Affordable Generics Act S. 1390: STRONGER Patents Act S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services Biopharmaceutical innovation and patent policy issues Patent litigation reform issues and issues related to post-grant proceedings at the PTO Bayh-Dole policy issues Venue in patent cases policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Health Issues HCR
S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 204: Trickett Wendler Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act H.R. 749: Lower Drug Costs Through Competition Act - Provisions related to generic drug approvals and priority review vouchers H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1231: RACE for Children Act - Provisions related to pediatric studies S. 456: RACE for Children Act - Provisions related to pediatric studies H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 H.R. 1776: Improving Access to Affordable Prescription Drugs Act Prescription Drug User Fee Act (PDUFA) reauthorization Biologics User Fee Act (BsUFA) reauthorization 340B drug discount program policy issues Orphan Drug Act policy issues Biologics Price Competition and Innovation Act (BPCIA) implementation issues Patient assistance program policy issues H.R. 2430: FDA Reauthorization Act of 2017 - Provisions related to user fee programs PL 114-255-21st Century Cures, implementation H.R. 749-Lower Drug Costs Through Competition Act Better Care Reconciliation Act of 2017 Graham-Cassidy Amendment H.R.2430/S.934: FDA Reauthorization Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
S. 41: Medicare Prescription Drug Price Negotiation Act of 2017 - Provisions related to Part D and drug pricing negotiation S. 251: Protecting Medicare from Executive Action Act of 2017 - Provisions related to repeal of the Independent Payment Advisory Board (IPAB) S. 260: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017 - Provisions related to Part D and drug pricing negotiation H.R. 849: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB H.J.Res. 51 - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal S.J.Res. 16 - A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal Part D policy issues including non-interference and rebates policy issues Drug cost and pricing policy issues Center for Medicare and Medicaid Innovation (CMMI) transparency and other policy issues H.R. 3921-Healthy Kids Act S. 1827- Kids Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Budget/Appropriations BUD
S.Con.Res 3: Budget Resolution - Provisions related to the biopharmaceutical industry including importation and non-interference H.R. 244: Consolidated Appropriations Act, 2017 Budget of the United States Government, Fiscal Year 2018 - A New Foundation for American Greatness Implementation of the Military Construction and Veterans Affairs and Related Agencies H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 H.R. 2810: National Defense Authorization Act for Fiscal Year 2018 H.R. 3219: Make America Secure Appropriations Act, 2018 H.R. 3268: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 H.Con.Res. 71: FY18 Budget Resolution S.Con.Res. __: FY 18 Budget Resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Trade (domestic/foreign) TRD
U.S. Trade policy, including IP and pharmaceutical market access issues Japan Pricing and Regulatory Issues U.S. IP policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Taxation/Internal Revenue Code TAX
Senate and House Committee Tax Reform Proposals Puerto Rican Economy and Debt Relief Proposals Proposals to reform domestic and international tax structures Implementation of the Puerto Rico Oversight, Management, and Economic Stability Act House Republican Tax Reform Blueprint and the Joint Statement on Tax Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON New | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.